What should be the final diagnosis for a patient with STEMI (ST-Elevation Myocardial Infarction) of the anteroseptal wall who underwent coronary angiography (CA) and percutaneous transluminal coronary angioplasty (PTCA) with stenting of the proximal to mid Left Anterior Descending (LAD) artery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Final Diagnosis for STEMI with Successful Revascularization

The final diagnosis should be: "Acute ST-Elevation Myocardial Infarction (STEMI) of the anteroseptal wall, status post successful primary percutaneous coronary intervention with drug-eluting stent placement to proximal-to-mid left anterior descending artery."

Essential Diagnostic Components

Primary Diagnosis Elements

  • Specify "Acute STEMI" rather than just "myocardial infarction" to indicate the ST-elevation presentation and acute nature of the event 1

  • Include anatomic location "anteroseptal wall" as this reflects the ECG territory and myocardial region affected by the LAD occlusion 1

  • Document "status post primary PCI" to indicate the reperfusion strategy employed, which is the Class I recommended treatment for STEMI within 12 hours of symptom onset 1

Procedural Details to Include

  • Specify stent type - if drug-eluting stent (DES) was used, this should be documented as it requires 12 months of dual antiplatelet therapy per guidelines 1

  • Document vessel and location - "proximal-to-mid LAD" identifies the culprit vessel and specific segment treated, which has prognostic implications 1, 2

  • Note "successful revascularization" if TIMI 3 flow was achieved, as this is the procedural goal and affects prognosis 1, 3

Additional Diagnostic Considerations

Complications or High-Risk Features

  • If cardiogenic shock was present, add "complicated by cardiogenic shock" as this dramatically changes prognosis and management 1

  • If left ventricular dysfunction was documented, include "with reduced ejection fraction" and the specific percentage 1

  • Document any mechanical complications such as ventricular septal defect or mitral regurgitation if present 1

Coronary Anatomy Beyond Culprit Lesion

  • Note multivessel disease if present - if angiography revealed significant stenoses in other vessels, document as "with multivessel coronary artery disease" since this affects long-term management and may require staged revascularization 1

  • The LAD location carries independent higher restenosis risk (OR 3.0) and warrants closer follow-up 2

Complete Diagnosis Format Example

"Acute ST-Elevation Myocardial Infarction of the anteroseptal wall, status post successful primary percutaneous coronary intervention with drug-eluting stent placement to proximal-to-mid left anterior descending artery, with TIMI 3 flow restoration"

Add if Applicable:

  • "with preserved left ventricular ejection fraction" or "with reduced LVEF (specify %)" 1
  • "complicated by [cardiogenic shock/ventricular arrhythmias/heart failure]" 1
  • "with multivessel coronary artery disease" if non-culprit lesions ≥50% stenosis were identified 1

Critical Documentation Elements

  • Time metrics - door-to-balloon time should be documented separately in the procedure note as quality metric (goal <90 minutes for PCI-capable hospitals) 1

  • Post-procedure antiplatelet regimen - aspirin plus P2Y12 inhibitor (prasugrel, ticagrelor, or clopidogrel) for 12 months is mandatory with DES 1

  • Risk stratification - proximal LAD involvement indicates higher-risk anatomy requiring aggressive secondary prevention 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Risk Assessment for Stent Stenosis and New Coronary Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the diagnosis and management for a 40% coronary artery lesion revealed by an angiogram?
What is the best course of management for an elderly patient with a history of breast cancer, presenting with chest pain and ST-elevation myocardial infarction (STEMI), occluded right coronary artery (RCA) where stenting is not feasible, diabetic ketoacidosis, respiratory alkalosis with metabolic acidosis, and right ventricular strain, currently on IV insulin and levophed (norepinephrine)?
What are the key components, assessment, and management of the cardiac system, including post-cardiac surgery care and Inferior STEMI (ST-Elevation Myocardial Infarction) in the Cardiovascular Intensive Care Unit (CVICU)?
At what percentage of blockage is stenting (percutaneous coronary intervention) typically considered during an angiogram?
A man of unspecified age, recently post-cholecystectomy, presents with chest pain and an ECG showing ST-Elevation Myocardial Infarction (STEMI) after initial management with oxygen, morphine, aspirin, and nitroglycerin, what's the next step?
What is the most appropriate management for an elderly male patient with diabetes mellitus (DM) and hypertension (HTN), as well as dyslipidemia, who had an ischemic stroke a few weeks ago and was managed with antiplatelets and physiotherapy, now presents with fatigue and has hyperglycemia?
What is the best course of action for a pregnant patient experiencing bleeding at 9 weeks gestation?
Can an elderly male diabetic patient with uncontrolled glucose levels and focal aware seizures presenting as facial spasms use carbamazepine and levetiracetam (Keppra) as treatment, given significant improvement with carbamazepine?
What is the recommended Non-Steroidal Anti-Inflammatory Drug (NSAID) treatment for a patient with plantar pain, considering potential renal function and gastrointestinal risk factors?
Is dicyclomine effective in treating gallbladder pain, particularly in patients with a history of conditions such as glaucoma, myasthenia gravis, or other conditions that may be exacerbated by anticholinergic medications?
What is the management approach for a patient with low Complement 3 (C3) levels, normal Complement 4 (C4) levels, and a normal Anti-Streptolysin O (ASO) titre?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.